LCTX Financials

Lineage Cell Therapeutics Inc - Financial statements & key metrics

Stock Price

$1.65

Market Cap

$425.94M

EPS

$-0.28

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$9.50M

Gross Profit

Operating Income

Net Income

$-18.58M

EPS (Diluted)

$-0.09

Balance Sheet Highlights

Total Assets

$113.22M

Total Liabilities

$36.21M

Shareholders Equity

Cash & Equivalents

$45.79M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-23.09M

CapEx

Free Cash Flow

Profitability Metrics

Gross Margin

-22.8%

Operating Margin

-1.0%

ROE

-1.1%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is LCTX revenue?

LCTX's most recent quarterly revenue was $9.50M. Annual revenue can be calculated by summing the four most recent quarters.

Is LCTX profitable?

LCTX reported a loss of $18.58M in the most recent quarter.

What is LCTX market cap?

LCTX has a market capitalization of $425.94M, making it a small-cap stock.

Does LCTX have debt?

View LCTX's balance sheet for debt information.

What is LCTX cash flow?

Cash flow data is available in the full financial statements.